Post featured image

Fran Lugo

Fecal Incontinence: Talking About It Is Part of the Treatment

Fecal incontinence remains one of the most under-discussed conditions in medicine. And that silence is often more damaging than the symptoms themselves.

On March 14, World Continence Day serves as a global reminder to educate and raise awareness about bladder and bowel control disorders. In the case of fecal incontinence, the stigma is still profound — yet the condition is far more common than most people realize.

The first step toward dignity is conversation.

Fecal incontinence is the inability to control bowel movements, resulting in the unintentional passage of stool. It can range from occasional leakage when passing gas to complete loss of bowel control.

Globally, 1 in 12 adults lives with fecal incontinence, representing approximately 27 million people (AGA, Clinical Gastroenterology and Hepatology, 2024).

In Mexico, it is estimated that 4.7% of the general population, with a mean age of 49.5 years, experiences fecal incontinence (Manual for the Health Care of Older Adults, Government of Mexico).

While prevalence increases with age, fecal incontinence is not a normal part of aging, nor is it an inevitable consequence of childbirth.

Normalizing the conversation does not mean normalizing the symptom.

Pelvic floor dysfunction is surrounded by embarrassment. Many patients delay seeking medical care for years due to shame, fear, or the belief that nothing can be done.

This delay has real consequences:

  • Social withdrawal
  • Anticipatory anxiety
  • Impact on intimacy
  • Loss of confidence

As a colorectal surgeon, I often witness how relief begins the moment patients understand that effective treatments exist. Education reduces stigma.

Fecal incontinence may result from several factors:

  • Pelvic floor muscle weakness
  • Obstetric injury
  • Neurological conditions
  • Hormonal changes, particularly in women
  • Diseases affecting the rectum or nerve pathways

Each case requires individualized evaluation. The cause, severity, and treatment approach vary from patient to patient.

Initial management often includes conservative strategies:

  • Pelvic floor muscle exercises
  • Pelvic rehabilitation therapy
  • Dietary adjustments
  • Medication management when appropriate

When these measures are insufficient, medical innovation offers minimally invasive solutions.

One of the most advanced options is Sacral Nerve Neuromodulation.

Sacral neuromodulation is a minimally invasive neuro-electrical stimulation therapy designed to improve communication between the brain and the nerves that control the colon and pelvic floor.

It works through:

  • Leads (electrodes) that deliver gentle electrical impulses near the sacral nerves
  • A neuromodulator device, similar to a pacemaker, implanted under the skin

The therapy is reversible and adjustable. A trial evaluation is conducted before permanent implantation to determine patient response.

Key benefits include:

  • No pharmacologic dependence
  • Maintenance of an active lifestyle
  • Significant improvement in symptom control

Medical innovation today allows us to offer solutions that were not available just a decade ago.

Fecal incontinence affects more than physical function. It impacts confidence, emotional wellbeing, and freedom.

Early diagnosis and timely treatment can dramatically change a patient’s experience. This is not merely about symptom control — it is about restoring dignity.

The message is clear:

  • Fecal incontinence is common.
  • It is not a source of shame.
  • It is not inevitable.
  • And it is treatable.

Encouraging open, respectful dialogue between patients, families, and healthcare professionals is a shared responsibility.

Talking about it is the first step.
Seeking care is the second.
Regaining quality of life is the goal.